These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 795438)

  • 21. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
    Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
    Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delta-9-Tetrahydrocannabinol: effect on mitochondrial swelling of different tissues of rat.
    Banerji A; Poddar MK; Ghosh JJ
    Methods Find Exp Clin Pharmacol; 1985 Jul; 7(7):351-6. PubMed ID: 2997559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Subjective changes with delta 9 trans-tetrahydrocannabinol in cannabis naive subjects].
    Dittrich A; Woggon B
    Int Pharmacopsychiatry; 1974; 9(3):138-51. PubMed ID: 4609941
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.
    Brenneisen R; Egli A; Elsohly MA; Henn V; Spiess Y
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):446-52. PubMed ID: 8897084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delta-9-tetrahydrocannabinol (THC) as an antiemetic.
    Huguley CM
    N Engl J Med; 1980 Jun; 302(24):1363-4. PubMed ID: 6246422
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of (--)delta-9-trans-tetrahydrocannabinol (delta-9-THC) on tests of psychoticism. A study of Eysenck's drug postulate on the effects of hallucinogens in relation to psychoticism (author's transl)].
    Dittrich A; Bickel P; Zimmer D
    Psychopharmacologia; 1975; 40(4):351-8. PubMed ID: 1096219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pilot study of orally administered Δ(1)-trans-tetrahydrocannabinol in the management of patients undergoing radiotherapy for carcinoma of the bronchus.
    Davies BH; Weatherstone RM; Graham JD; Griffiths RD
    Br J Clin Pharmacol; 1974 Aug; 1(4):301-6. PubMed ID: 22454883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subjective syndromes, physiological changes and after-effects of the acute 9-tetrahydrocannabinol intoxication. Two double-blind studies in volunteers.
    Dittrich A; Woggon B
    Arch Psychiatr Nervenkr (1970); 1972; 216(3):301-9. PubMed ID: 4564855
    [No Abstract]   [Full Text] [Related]  

  • 29. A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ⁸-Tetrahydrocannabinol.
    Sultan SR; Millar SA; O'Sullivan SE; England TJ
    Pharmaceuticals (Basel); 2018 Jan; 11(1):. PubMed ID: 29385080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers for the effects of cannabis and THC in healthy volunteers.
    Zuurman L; Ippel AE; Moin E; van Gerven JM
    Br J Clin Pharmacol; 2009 Jan; 67(1):5-21. PubMed ID: 19133057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bayesian restoration of ion channel records using hidden Markov models.
    Rosales R; Stark JA; Fitzgerald WJ; Hladky SB
    Biophys J; 2001 Mar; 80(3):1088-103. PubMed ID: 11222275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of non-identifiability on testing for detailed balance in aggregated Markov models for ion-channel gating.
    Wagner M; Timmer J
    Biophys J; 2000 Dec; 79(6):2918-24. PubMed ID: 11106600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
    Curran HV; Brignell C; Fletcher S; Middleton P; Henry J
    Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of simple somatic parameters by delta-9-trans-tetrahydrocannabinol (delta-9-THC) in a double-blind-study. Short communication.
    Zimmer BD; Bickel P; Dittrich A
    Arzneimittelforschung; 1976; 26(8):1614-6. PubMed ID: 795438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine.
    Roberts JD; Gennings C; Shih M
    Eur J Pharmacol; 2006 Jan; 530(1-2):54-8. PubMed ID: 16375890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
    Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM
    Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.